4//SEC Filing
MAHON PAUL A 4
Accession 0001231589-26-000002
CIK 0001082554other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 4:32 PM ET
Size
18.5 KB
Accession
0001231589-26-000002
Insider Transaction Report
Form 4
MAHON PAUL A
EVP & GENERAL COUNSEL
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-15$146.03/sh+8,300$1,212,049→ 45,081 total - Sale
Common Stock
[F1][F2]2026-01-15$468.32/sh−1,439$673,918→ 43,642 total - Sale
Common Stock
[F1][F3]2026-01-15$470.37/sh−1,307$614,769→ 42,335 total - Sale
Common Stock
[F1][F4]2026-01-15$472.28/sh−407$192,219→ 41,928 total - Sale
Common Stock
[F1][F5]2026-01-15$469.34/sh−3,531$1,657,237→ 38,397 total - Sale
Common Stock
[F1][F6]2026-01-15$471.44/sh−1,576$742,990→ 36,821 total - Sale
Common Stock
[F1]2026-01-15$474.74/sh−40$18,990→ 36,781 total - Exercise/Conversion
Stock Option
[F1]2026-01-15−8,300→ 58,400 totalExercise: $146.03From: 2020-03-15Exp: 2027-03-15→ Common Stock (8,300 underlying)
Footnotes (6)
- [F1]This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $467.815 to $468.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $469.92 to $470.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $472.13 to $472.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $468.84 to $469.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $471.00 to $471.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Signature
/s/ John S. Hess, Jr. under Power of Attorney|2026-01-15
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001231589
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 4:32 PM ET
- Size
- 18.5 KB